Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The Yersinia Type III secretion effector YopM Is an E3 ubiquitin ligase that induced necrotic cell death by targeting NLRP3.

Wei C, Wang Y, Du Z, Guan K, Cao Y, Yang H, Zhou P, Wu F, Chen J, Wang P, Zheng Z, Zhang P, Zhang Y, Ma S, Yang R, Zhong H, He X.

Cell Death Dis. 2016 Dec 8;7(12):e2519. doi: 10.1038/cddis.2016.413.

2.

The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.

Ratner D, Orning MP, Proulx MK, Wang D, Gavrilin MA, Wewers MD, Alnemri ES, Johnson PF, Lee B, Mecsas J, Kayagaki N, Goguen JD, Lien E.

PLoS Pathog. 2016 Dec 2;12(12):e1006035. doi: 10.1371/journal.ppat.1006035. eCollection 2016 Dec.

3.

The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.

Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL, Chae JJ, Bliska JB.

Cell Host Microbe. 2016 Sep 14;20(3):296-306. doi: 10.1016/j.chom.2016.07.018. Epub 2016 Aug 25.

4.

Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells.

Berneking L, Schnapp M, Rumm A, Trasak C, Ruckdeschel K, Alawi M, Grundhoff A, Kikhney AG, Koch-Nolte F, Buck F, Perbandt M, Betzel C, Svergun DI, Hentschke M, Aepfelbacher M.

PLoS Pathog. 2016 Jun 14;12(6):e1005660. doi: 10.1371/journal.ppat.1005660. eCollection 2016 Jun.

5.

Distribution and Evolution of Yersinia Leucine-Rich Repeat Proteins.

Hu Y, Huang H, Hui X, Cheng X, White AP, Zhao Z, Wang Y.

Infect Immun. 2016 Jul 21;84(8):2243-54. doi: 10.1128/IAI.00324-16. Print 2016 Aug.

6.

Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.

Ratner D, Orning MP, Starheim KK, Marty-Roix R, Proulx MK, Goguen JD, Lien E.

J Biol Chem. 2016 May 6;291(19):9894-905. doi: 10.1074/jbc.M115.697698. Epub 2016 Feb 16. Erratum in: J Biol Chem. 2016 Jul 29;291(31):16417.

7.

Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.

Schoberle TJ, Chung LK, McPhee JB, Bogin B, Bliska JB.

Infect Immun. 2016 Mar 24;84(4):1062-72. doi: 10.1128/IAI.00843-15. Print 2016 Apr.

8.

Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague.

Stasulli NM, Eichelberger KR, Price PA, Pechous RD, Montgomery SA, Parker JS, Goldman WE.

MBio. 2015 Oct 13;6(5):e01530-15. doi: 10.1128/mBio.01530-15.

9.

Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.

Rosenheinrich M, Heine W, Schmühl CM, Pisano F, Dersch P.

PLoS One. 2015 Aug 21;10(8):e0136290. doi: 10.1371/journal.pone.0136290. eCollection 2015.

10.

Manipulation of pro-inflammatory cytokine production by the bacterial cell-penetrating effector protein YopM is independent of its interaction with host cell kinases RSK1 and PRK2.

Höfling S, Scharnert J, Cromme C, Bertrand J, Pap T, Schmidt MA, Rüter C.

Virulence. 2014;5(7):761-71. doi: 10.4161/viru.29062.

11.

Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen.

Ye Z, Gorman AA, Uittenbogaard AM, Myers-Morales T, Kaplan AM, Cohen DA, Straley SC.

PLoS One. 2014 Nov 5;9(11):e110956. doi: 10.1371/journal.pone.0110956. eCollection 2014.

12.

IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM.

Chung LK, Philip NH, Schmidt VA, Koller A, Strowig T, Flavell RA, Brodsky IE, Bliska JB.

MBio. 2014 Jul 1;5(4):e01402-14. doi: 10.1128/mBio.01402-14.

13.

Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.

Westermark L, Fahlgren A, Fällman M.

Infect Immun. 2014 Mar;82(3):1181-91. doi: 10.1128/IAI.01634-13. Epub 2013 Dec 30.

14.

Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors.

Bliska JB, Wang X, Viboud GI, Brodsky IE.

Cell Microbiol. 2013 Oct;15(10):1622-31. doi: 10.1111/cmi.12164. Epub 2013 Jul 29. Review.

15.

Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac protein.

Wolters M, Boyle EC, Lardong K, Trülzsch K, Steffen A, Rottner K, Ruckdeschel K, Aepfelbacher M.

J Biol Chem. 2013 Aug 9;288(32):23543-53. doi: 10.1074/jbc.M112.448662. Epub 2013 Jun 26.

16.

Toward a molecular pathogenic pathway for Yersinia pestis YopM.

Uittenbogaard AM, Chelvarajan RL, Myers-Morales T, Gorman AA, Brickey WJ, Ye Z, Kaplan AM, Cohen DA, Ting JP, Straley SC.

Front Cell Infect Microbiol. 2012 Dec 11;2:155. doi: 10.3389/fcimb.2012.00155. eCollection 2012.

17.

The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing.

LaRock CN, Cookson BT.

Cell Host Microbe. 2012 Dec 13;12(6):799-805. doi: 10.1016/j.chom.2012.10.020.

18.

Tracing genomic variations in two highly virulent Yersinia enterocolitica strains with unequal ability to compete for host colonization.

Garzetti D, Bouabe H, Heesemann J, Rakin A.

BMC Genomics. 2012 Sep 11;13:467. doi: 10.1186/1471-2164-13-467.

19.

Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis.

Galindo CL, Rosenzweig JA, Kirtley ML, Chopra AK.

J Pathog. 2011;2011:182051. doi: 10.4061/2011/182051. Epub 2011 Sep 12.

20.

Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.

McPhee JB, Mena P, Zhang Y, Bliska JB.

Infect Immun. 2012 Jul;80(7):2519-27. doi: 10.1128/IAI.06364-11. Epub 2012 Apr 30.

Supplemental Content

Support Center